Compare ASTI & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASTI | NEPH |
|---|---|---|
| Founded | 2005 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9M | 40.1M |
| IPO Year | 2014 | 2004 |
| Metric | ASTI | NEPH |
|---|---|---|
| Price | $3.93 | $3.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $20.00 | $6.00 |
| AVG Volume (30 Days) | ★ 662.8K | 8.8K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 70.23 | ★ 1000.00 |
| EPS | N/A | ★ 0.01 |
| Revenue | $10,398,149.00 | ★ $18,789,000.00 |
| Revenue This Year | N/A | $11.24 |
| Revenue Next Year | N/A | $11.58 |
| P/E Ratio | ★ N/A | $360.00 |
| Revenue Growth | ★ 163.25 | 32.67 |
| 52 Week Low | $1.40 | $2.66 |
| 52 Week High | $9.87 | $6.42 |
| Indicator | ASTI | NEPH |
|---|---|---|
| Relative Strength Index (RSI) | 35.66 | 49.70 |
| Support Level | $3.34 | $2.77 |
| Resistance Level | $4.68 | $3.78 |
| Average True Range (ATR) | 0.40 | 0.25 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 7.72 | 34.90 |
Ascent Solar Technologies Inc is a solar technology company that manufactures and sells photovoltaic (PV) solar modules that are flexible, durable, and possess attractive power to weight and power to area performance. Its technology provides renewable power solutions to high-value production and specialty solar markets where traditional rigid solar panels are not suitable, including space power beaming, aerospace, satellites, near earth orbiting vehicles, fixed wing unmanned aerial vehicles (UAV), aquatic, terrestrial, and other weight-sensitive markets with transformational high quality, value added product applications. It operates in single PV segment that sells PV products and engineering services and currently, is selling it in North America.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.